Surge Biswas is the cofounder and CEO of Nabla Bio, an AI platform to enable precise drug design and high-throughput measurement of drug properties. They recently raised $26M Series A led by Radical Ventures. He has a PhD in Bioinformatics and Integrative Genomics from Harvard University.

Surge's favorite book: Permutation City (Author: Greg Egan)

(00:01 ) Introduction
(00:07 ) Generative AI in Drug Design
(01:19 ) Traditional vs. AI-driven Drug Discovery
(03:42 ) Designing Antibodies
(05:06 ) Therapeutic Antibodies Design Process
(07:39 ) Data Sets for AI in Drug Discovery
(10:48 ) High Throughput Measurement in Drug Discovery
(13:14 ) Setting Up High Throughput Screening Assays
(18:46 ) Multiplexed Screens in Drug Discovery
(21:55 ) Protein Characterization Techniques
(24:33 ) Protein-Protein Interactions
(28:12 ) AI in Protein Characterization
(30:55 ) Technological Breakthroughs in AI and Bio
(32:36 ) Rapid Fire Round
(36:27 ) Conclusion

--------
Where to find Prateek Joshi:

Newsletter: https://prateekjoshi.substack.com 
Website: https://prateekj.com 
LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19 
Twitter: https://twitter.com/prateekvjoshi